We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$251M
AUM Growth
+$9.77M
Cap. Flow
-$5.29M
Cap. Flow %
-2.11%
Top 10 Hldgs %
13.15%
Holding
258
New
40
Increased
80
Reduced
24
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 23.99%
2 Healthcare 17.12%
3 Consumer Discretionary 12.37%
4 Communication Services 10.85%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEPI
251
DELISTED
AEP Industries Inc
AEPI
-13,600
Closed -$1.58M
SBNY
252
DELISTED
Signature Bank
SBNY
-6,443
Closed -$968K
NEWS
253
DELISTED
NewStar Financial, Inc.
NEWS
-60,304
Closed -$558K
WNR
254
DELISTED
Western Refining Inc
WNR
-52,000
Closed -$1.97M
ENV
255
DELISTED
ENVESTNET, INC.
ENV
-32,275
Closed -$1.14M
MNR
256
DELISTED
Monmouth Real Estate Investment Corp
MNR
-80,038
Closed -$1.22M
SWFT
257
DELISTED
Swift Transportation Company
SWFT
-55,352
Closed -$1.35M
HR
258
DELISTED
Healthcare Realty Trust Incorporated
HR
-30,937
Closed -$938K

Similar funds

Capital Impact Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Capital Impact Advisors held 258 positions worth $251M, up 4% from $241M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Capital Impact Advisors's Q1 2017 filing shows 40 new, 80 increased, 24 reduced and 99 closed positions. Its largest new stake was SS&C Technologies: 93,104 shares worth $3.3M. The largest sale was United Therapeutics, an estimated $2.89M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's largest Q1 2017 buy was SS&C Technologies: 93,104 shares worth $3.3M.
  • Capital Impact Advisors added most to Alphabet (Google) Class A in Q1 2017, an estimated $2.9M increase.
  • Capital Impact Advisors's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $2.89M.
  • Capital Impact Advisors fully exited Huntsman Corp in Q1 2017, selling an estimated $2.66M.
  • Capital Impact Advisors's ten largest holdings make up 13% of its $251M portfolio in Q1 2017.
  • Capital Impact Advisors opened 40 new positions and closed 99 in Q1 2017.
  • Capital Impact Advisors's portfolio value rose 4% quarter-over-quarter to $251M.

Based on Capital Impact Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.